Medical Developments International (ASX: MVP) Providing An Alternative To Opioid Addiction
Medical Developments International (ASX:MVP) shares look attractive at current prices given the potential for significant Penthrox sales growth.
Medical Developments International (ASX:MVP) shares look attractive at current prices given the potential for significant Penthrox sales growth.
Macquarie notes that Sezzle’s Appstore ranking has improved, but their analysis barely scratches the surface. Are Sezzle (ASX:SZL) shareholders in the dark?
These three stocks have seen insider buying and have decent prospects in the next few years.
The Little Book of Behavioural Investing by James Montier stresses the importance of being process focused as opposed to outcome focused…
Appen (ASX: APX) shares are a potentially interesting investment, but investors should focus on the key drivers of the business, not EBITDA multiples.
The EML Payments (ASX:EML) share price is down around 34% on regulatory concerns that could undermine its reputation globally.
Volatile markets are seeing growth stocks crash, value stocks climb, and dogecoin attract new suckers like iron filings to a magnet.
One of the easiest ways to get started as an ethical investor is to buy one of these ASX listed ethical ETFs.
My original Whispir (ASX: WSP) thesis has played out nicely but I no longer find the risk vs reward attractive.
Less than a year after we published “The Case For Alcidion” the stock is up 160%, so it’s time to revisit the thesis.
Dusk Group (ASX:DSK) isn’t the kind of software compounder I love most, but it is arguably a short term trade set up…
Adir Shiffman, executive chairman of Catapult International, has been sharing some interesting tweets about covid-19.
8Common (ASX: 8CO) and Mach7 Technologies (ASX: M7T) are two small Aussie software stocks with strong share price momentum.
This makes the claimed “remaining short to medium term enterprise pipeline of some 15-20,000 connected vehicles,” in Australia seem more achievable than ever.
SkyFii’s acquisition of CrowdVision will add annualised recurring revenues (ARR) of around $2.3m (AUD) bringing pro forma SkyFii ARR to $13.3m.
Eleanor Dawson was a psychiatrist, 1950s career woman, mother and grandmother.
Adding to losing positions is often a dangerous game, even for professionals. Here’s why my default position is to avoid chasing my losses as an investor.
By cultivating a strong relationship with retail shareholders, Rightcrowd (ASX:RCW) could increase its capital raising options…
These 3 stocks remained profitable throughout the pandemic, are positioned for a stronger 2021, and are not too far from attractive value…
“In 3 – 5years we want to be a $100 million revenue company and be profitable and grow that profit.”